Lawsuit for Investors in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) announced by Shareholders Foundation


SAN DIEGO, Jan. 18, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain purchasers of shares of Abeona Therapeutics Inc (NASDAQ:ABEO) over alleged Securities Laws Violations by Abeona Therapeutics Inc.

Investors who purchased shares of Abeona Therapeutics Inc (NASDAQ: ABEO) have certain options and for certain investors there are short and strict deadlines running. Deadline: February 14, 2017. NASDAQ:ABEO investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the science behind Abeona’s proposed gene therapy treatment for Sanfilippo syndrome is unviable, that Steven H. Rouhandeh, Abeona Therapeutics, Inc’s Executive Chairman and Principal Executive Officer, previously worked in a high ranking position for a biotech promoter who was convicted of securities fraud and involved in manipulating biotech stocks, and that as a result, Defendants’ statements about Abeona Therapeutics, Inc’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased Abeona Therapeutics Inc (NASDAQ: ABEO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.


            

Coordonnées